Related Experiment Video

Updated: May 25, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

Rap1GAP regulates renal cell carcinoma invasion

Wan-Ju Kim1, Zachary Gersey, Yehia Daaka

  • 1Department of Urology, Prostate Disease Center, University of Florida College of Medicine, Gainesville, FL, United States.

Cancer Letters
|January 24, 2012
PubMed

Insights

Restoring Rap1GAP expression in kidney cancer cells reduces their invasion and metastasis. This finding offers a potential therapeutic strategy for advanced renal cell carcinoma (RCC).

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Metastatic kidney cancer (renal cell carcinoma, RCC) poses a significant mortality risk.
  • Understanding the molecular drivers of RCC cell invasion is crucial for developing effective therapies.
  • The small GTPase Rap1 and its regulator Rap1GAP are implicated in cancer progression.

Purpose of the Study:

  • To investigate the role of Rap1GAP in the migratory and invasive properties of renal cell carcinoma (RCC) cells.
  • To correlate Rap1GAP expression levels with invasion and migration in RCC.
  • To explore therapeutic strategies targeting Rap1GAP in kidney cancer.

Main Methods:

  • Profiling migratory and invasive properties of RCC cell lines.
  • Correlating Rap1GAP expression with invasion and migration.
  • Over-expressing Rap1GAP in RCC cells.
  • Analyzing the effect of Rap1GAP on cell proliferation.
  • Investigating the role of promoter hypermethylation in Rap1GAP downregulation.
  • Using decitabine (5-azadC) to rescue Rap1GAP expression.
  • Assessing the impact of Rap1GAP on cell adhesion proteins (cadherins and integrins).

Main Results:

  • Rap1GAP levels inversely correlated with RCC cell invasion, but not migration.
  • Forced Rap1GAP over-expression reduced RCC cell invasion without affecting proliferation.
  • Promoter hypermethylation was identified as a cause for low Rap1GAP expression.
  • Decitabine treatment restored Rap1GAP expression and decreased RCC cell invasion.
  • Rap1GAP over-expression attenuated levels of cadherins and integrins, impacting cell invasion.

Conclusions:

  • Rap1GAP plays a critical role in regulating the invasiveness of renal cell carcinoma cells.
  • Targeted restoration of Rap1GAP expression may represent a novel therapeutic approach to inhibit kidney cancer metastasis.
  • Understanding the epigenetic regulation of Rap1GAP (e.g., promoter hypermethylation) is important for therapeutic development.

More Related Videos

Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy

Published on: April 29, 2014

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.